More intriguingly, they showed that the increased expression levels of RIG-I and MDA5 by interferon stimulation could mediate immune response and allow hitting different GB malignant cells, including cancer stem cells, with low level of neurotoxicity. The gene discussed is IFIH1; the disease is cancer.